Patent · US Active

Anti-EDB antibodies and antibody-drug conjugates

US11833216B2 · kind B2 · utility

0Cited by
18References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 9, 2023
Grant dateDec 5, 2023
Priority date
Expiry dateFeb 9, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides antibodies and antibody-drug conjugates that bind to the extra domain B splice variant of fibronectin 1 and methods for preparing and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.